In addition, the AP-2α deletion mutant, which can saliently interfere with the transcriptional activation function of each AP-2 member, not only inhibited the ErbB3 promoter activity but also suppressed ErbB3 transcription in the ErbB3-overexpression breast cancer cell lines[177]. This evidence concerns the gene ERBB3 and breast carcinoma.